A Study to Evaluate the Safety and Tolerability of ONL1204 in Patients With Macula-off, Rhegmatogenous Retinal Detachment
Condition(s):Rhegmatogenous Retinal Detachment – Macula OffLast Updated:October 10, 2022Completed
Hide Studies Not Open or Pending
Condition(s):Rhegmatogenous Retinal Detachment – Macula OffLast Updated:October 10, 2022Completed
Condition(s):Photobiomodulation; Age-Related Macular DegenerationLast Updated:October 12, 2022Not yet recruiting
Condition(s):Diabetic RetinopathyLast Updated:March 21, 2023Not yet recruiting
Condition(s):Macular Edema; Visual AcuityLast Updated:September 19, 2013Completed
Condition(s):Retinal DetachmentLast Updated:September 9, 2020Completed
Condition(s):Idiopathic Macula HoleLast Updated:June 19, 2018Completed
Condition(s):Macular HolesLast Updated:December 9, 2020Completed
Condition(s):Persons Issued From Amd ParentsLast Updated:May 20, 2013Completed
Condition(s):Thyroid Associated OphthalmopathyLast Updated:May 10, 2016Completed
Condition(s):Rhegmatogenous Retinal Detachment – Macula OffLast Updated:February 29, 2024Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.